Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder

NCT04641143 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

456

Enrollment

INDUSTRY

Sponsor class

Conditions

Obsessive-Compulsive Disorder

Interventions

DRUG: Troriluzole
DRUG: Placebo

Sponsor

Biohaven Pharmaceuticals, Inc.